TABLE 5.
Differentiating Manifestations in 44 Patients With a DM Phenotype, Divided According to the Absence or Presence of Overlap Clinical Features at Last Follow-Up: Duration of Cutaneous DM, Muscle Manifestations, and Serum Autoantibodies
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.